SUMMARY Sixteen women with multiple sclerosis who complained of nocturia completed a double-blind cross-over trial of Desmopressin (DDAVP) and placebo. Nocturia was reduced from a mean of 2.55 voids to 2*01 with placebo and to 1-28 with Desmopressin (p < 0-01, for the difference between placebo and Desmopressin). Side effects were minor, and equally distributed between treatment and placebo.
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Desmopressin has been used to treat enuresis' and nocturia23 in patients with a variety of urodynamic diagnoses. This trial was undertaken to follow-up our earlier observation that patients with multiple sclerosis benefited from Desmopressin.3
Patients and methods
Sixteen women with multiple sclerosis who complained of nocturia (waking from sleep to void on two or more occasions each night) were included in a double-blind crossover study comparing Desmopressin and placebo. The treatments were given at bed-time, in the form of an intranasal spray; the dose of Desmopressin was 20 mcg. The initial assessment included history, physical examination, a 7-day urinary diary, and a mid-stream urine specimen for culture. Grounds for exclusion were a history of impaired renal function, ischaemic heart disease, hypertension, or urinary infection. Treatment order was randomly allocated; nine patients took Desmopressin first, and seven took placebo first. During each treatment phase the patients kept a urinary diary. On the last day of each treatment phase a questionnaire of symptoms and sideeffects was completed, and measurements of blood pressure, plasma osmolality, electrolytes and urea, and early morning urine osmolality, made. Results were analysed using paired t-tests. 
